Our pellets are now being produced by Belmar Select Outsourcing (BSO). The great news is that the same quality and high standards used at Belmar Pharmacy, now meet cGMP and FDA requirements. BSO is a cGMP and FDA registered 503B Outsourcing Facility for hormone pellet implants. BSO is licensed in 35 states and we have a two-day turnaround shipping out your pellet orders.
Belmar Select Outsourcing's mission is to provide quality hormone pellet implants to clinicians at a reasonable price.  We use state of the art methodology to compound manufacture our hormone pellet implants in estradiol, testosterone, testosterone with cholesterol, progesterone, and anastrozole.  Our pellets are sterilized using the most advanced sterilization technique uniquely suited for this dosage form.  Every batch is tested for potency and endotoxins.  We have also implemented a risk-based environmental monitoring program.Because we are a 503B Outsourcing Facility, we do not require patient specific prescriptions and can ship the pellets to your office in bulk.  We do not require contracts when working with us.  
Call or visit our website for available pellet strengths: 
T: (877) 267-3410 | (303) 963-5488 


Britto, R., Araújo, L., Barbosa, I. and Silva, L. (2012). Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants. Gynecological Endocrinology, 28(10), pp.767-769. 

Cravioto, M., Larrea, F., Delgado, N., Escobar, A., Díaz-Sánchez V, Domínguez J, de León RP. (2001). Pharmacokinetics and pharmacodynamics of 25-mg estradiol implants in postmenopausal Mexican women. Menopause, 8(5), pp.353-360.
Greenblatt, R., Bryner, J., Mahesh, V. and Asch, R. (1977). Implantation of pure crystalline pellets of estradiol for conception control. Am J Obstet Gynecol., 127(5), pp.520-4.

Kelleher, Turner, Howe, Conway, and Handelsman, (1999). Extrusion of testosterone pellets: a randomized controlled clinical study. Clin Endocrinol, 51(4), pp.469-471.
Pastuszak, A., Mittakanti, H., Liu, J., Gomez, L., Lipshultz, L. and Khera, M. (2012).Pharmacokinetic Evaluation and Dosing of Subcutaneous Testosterone Pellets. Journal of Andrology, 33(5), pp.927-937.
Stanczyk, F., Shoupe, D., Nunez, V., Macias-Gonzales, P., Vijod, M. and Lobo, R. (1988). A randomized comparison of nonoral estradiol delivery in postmenopausal women.  American Journal of Obstetrics and Gynecology, 159(6), pp.1540-1546. 

Studd, J., Savvas, M., Waston, N., Garnett, T., Fogelman, I. and Cooper, D. (1990). The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. American Journal of Obstetrics and Gynecology, 163(5), pp.1474-1479.



Belmar Pharmacy  800.525.9473  I  303.763.5533  I  231 Violet Street, Suite 140  I  Golden, CO 80401